Literature DB >> 8162460

High prevalence of joint laxity in West Africans.

F N Birrell1, A O Adebajo, B L Hazleman, A J Silman.   

Abstract

Previous surveys have suggested marked ethnic and geographical variation in the occurrence of joint hypermobility. We investigated the prevalence of joint hypermobility and the influences of age, sex, body mass and occupation in a rural Yoruba population in Nigeria. The study sample consisted of 204 individuals aged 6-66 yr from the townships of Igbo-ora and Eruwa in south western Nigeria. Sixty-eight had reported joint pain as part of a population survey of arthritic disorders and each was age and sex matched with one household and one neighbour control. Joint hypermobility was assessed, at four peripheral sites bilaterally and forward flexion of the trunk, by a single observer using the Beighton score. Each subject had weight and height recorded, answered a brief questionnaire about occupation and joint symptoms and was examined for peripheral joint disease. Only 11 (5%) of the subjects were negative at all five sites whereas 111 (54%) were hypermobile at three or more sites including 23 (11%) positive at all five. Using a score of 4/9 or greater as a cutoff, 88 (43%) were positive, including 35% of males and 57% of females. There was a linear decline with age in females but a more rapid decline only to age 35 yr in males. There was no relation to body mass or occupation. We conclude that joint hypermobility amongst this population is substantially greater than that recorded for other groups but is not associated with joint pain.

Entities:  

Mesh:

Year:  1994        PMID: 8162460     DOI: 10.1093/rheumatology/33.1.56

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  17 in total

Review 1.  Joint hypermobility and genetic collagen disorders: are they related?

Authors:  R Grahame
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

2.  Relationship of Q angle and joint hypermobility and Q angle values in different positions.

Authors:  Omer Faruk Sendur; Gulcan Gurer; Tuncay Yildirim; Emine Ozturk; Ali Aydeniz
Journal:  Clin Rheumatol       Date:  2005-10-06       Impact factor: 2.980

Review 3.  Hypermobility.

Authors:  P Klemp
Journal:  Ann Rheum Dis       Date:  1997-10       Impact factor: 19.103

4.  Multimodal chiropractic care of pain and disability for a patient diagnosed with benign joint hypermobility syndrome: a case report.

Authors:  Richard G Strunk; Mark T Pfefer; Derrick Dube
Journal:  J Chiropr Med       Date:  2014-03

5.  Incidence of joint hypermobility syndrome in a military population: impact of gender and race.

Authors:  Danielle L Scher; Brett D Owens; Rodney X Sturdivant; Jennifer Moriatis Wolf
Journal:  Clin Orthop Relat Res       Date:  2010-07       Impact factor: 4.176

6.  Prevalence of joint hypermobility and patterns of articular manifestations in patients with inflammatory bowel disease.

Authors:  P Vounotrypidis; E Efremidou; P Zezos; M Pitiakoudis; E Maltezos; N Lyratzopoulos; G Kouklakis
Journal:  Gastroenterol Res Pract       Date:  2010-02-11       Impact factor: 2.260

Review 7.  Anterior cruciate ligament reconstruction in patients with generalized joint laxity.

Authors:  Sung-Jae Kim; Praveen Kumar; Sung-Hwan Kim
Journal:  Clin Orthop Surg       Date:  2010-08-03

8.  Clinical management of benign joint hypermobility syndrome: a case series.

Authors:  Patricia Adele Boudreau; Igor Steiman; Silvano Mior
Journal:  J Can Chiropr Assoc       Date:  2020-04

Review 9.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

10.  Dermal ultrastructure in low Beighton score members of 17 families with hypermobile-type Ehlers-Danlos syndrome.

Authors:  Trinh Hermanns-Lê; Marie-Annick Reginster; Claudine Piérard-Franchimont; Philippe Delvenne; Gérald E Piérard; Daniel Manicourt
Journal:  J Biomed Biotechnol       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.